Cervical cancer occurs in approximately 500,000 women and kills 288,000 women
worldwide each year. Prognosis is highly dependent on disease stage at diagnosis. When …

Cancer of the cervix is the second most common malignancy among women worldwide. The
last 20 years have lead to numerous advances in the medical management of locally …

In recent years, the treatment of locally-advanced and metastatic cervical cancer has
improved greatly due to the introduction of targeted therapies, new chemotherapy …

Cervical cancer is the second most frequent malignancy affecting women worldwide. The
highest incidences occur in the developing world, where, in most countries, cervical cancer …

Importance of the field: Cervical cancer (CC) remains an important health problem. It is the
second most frequent malignancy in women worldwide, with one-third of patients dying from …

Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Purpose The purpose of this study was to provide an overview of current and up and coming
targeted therapies in cervical cancer with or without chemotherapy. Methods We reviewed …

Introduction: Cervical cancer is the fourth leading cause of cancer death in females
worldwide. Incorporation of chemotherapy to radiation in locally advanced disease and …

Immunotherapy has been a breakthrough in the treatment of several cancers with limited
adverse effects compared to other therapies. Patients have experienced remission with …

Worldwide, cervical cancer is one of the most common cancers in women [1]. About 450,000
women are diagnosed with cervical cancer each year around the world, and another …